

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 6.63834045 |
| 2 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.48690878 |
| 3 | carnitine shuttle (GO:0006853) | 5.44544699 |
| 4 | regulation of sequestering of triglyceride (GO:0010889) | 5.03696127 |
| 5 | fatty acid transmembrane transport (GO:1902001) | 5.01941430 |
| 6 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.73886832 |
| 7 | carnitine transmembrane transport (GO:1902603) | 4.67687287 |
| 8 | valine metabolic process (GO:0006573) | 4.64297982 |
| 9 | regulation of cofactor metabolic process (GO:0051193) | 4.60840013 |
| 10 | regulation of coenzyme metabolic process (GO:0051196) | 4.60840013 |
| 11 | sarcomere organization (GO:0045214) | 4.60196471 |
| 12 | amino-acid betaine transport (GO:0015838) | 4.42544049 |
| 13 | carnitine transport (GO:0015879) | 4.42544049 |
| 14 | establishment of integrated proviral latency (GO:0075713) | 4.40353617 |
| 15 | fatty acid beta-oxidation (GO:0006635) | 4.31240613 |
| 16 | chromatin remodeling at centromere (GO:0031055) | 4.29441833 |
| 17 | tricarboxylic acid metabolic process (GO:0072350) | 4.23464927 |
| 18 | NADH metabolic process (GO:0006734) | 4.22498287 |
| 19 | actin-myosin filament sliding (GO:0033275) | 4.21062475 |
| 20 | muscle filament sliding (GO:0030049) | 4.21062475 |
| 21 | CENP-A containing nucleosome assembly (GO:0034080) | 4.20194135 |
| 22 | DNA ligation (GO:0006266) | 4.11681855 |
| 23 | lipid particle organization (GO:0034389) | 4.05204604 |
| 24 | cardiac myofibril assembly (GO:0055003) | 4.04145790 |
| 25 | non-recombinational repair (GO:0000726) | 4.01523492 |
| 26 | double-strand break repair via nonhomologous end joining (GO:0006303) | 4.01523492 |
| 27 | regulation of fatty acid oxidation (GO:0046320) | 3.94178645 |
| 28 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.93984276 |
| 29 | lysine catabolic process (GO:0006554) | 3.91639329 |
| 30 | lysine metabolic process (GO:0006553) | 3.91639329 |
| 31 | biotin metabolic process (GO:0006768) | 3.81624527 |
| 32 | 2-oxoglutarate metabolic process (GO:0006103) | 3.81444514 |
| 33 | DNA damage response, detection of DNA damage (GO:0042769) | 3.80970397 |
| 34 | oxidative phosphorylation (GO:0006119) | 3.74336282 |
| 35 | branched-chain amino acid catabolic process (GO:0009083) | 3.73301414 |
| 36 | regulation of sulfur metabolic process (GO:0042762) | 3.58100369 |
| 37 | branched-chain amino acid metabolic process (GO:0009081) | 3.57553491 |
| 38 | myofibril assembly (GO:0030239) | 3.55896503 |
| 39 | DNA replication-independent nucleosome organization (GO:0034724) | 3.55443089 |
| 40 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.55443089 |
| 41 | histone exchange (GO:0043486) | 3.53340085 |
| 42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.51679507 |
| 43 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.49942300 |
| 44 | oxaloacetate metabolic process (GO:0006107) | 3.48356140 |
| 45 | pentose-phosphate shunt (GO:0006098) | 3.46133668 |
| 46 | DNA unwinding involved in DNA replication (GO:0006268) | 3.45729844 |
| 47 | fatty acid catabolic process (GO:0009062) | 3.45588478 |
| 48 | succinate metabolic process (GO:0006105) | 3.42693733 |
| 49 | fatty acid oxidation (GO:0019395) | 3.41404007 |
| 50 | nuclear pore complex assembly (GO:0051292) | 3.41071532 |
| 51 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.38572441 |
| 52 | cullin deneddylation (GO:0010388) | 3.38530322 |
| 53 | aspartate family amino acid catabolic process (GO:0009068) | 3.37479088 |
| 54 | regulation of translational fidelity (GO:0006450) | 3.34258765 |
| 55 | DNA strand elongation (GO:0022616) | 3.33302182 |
| 56 | low-density lipoprotein particle clearance (GO:0034383) | 3.32835227 |
| 57 | lipid oxidation (GO:0034440) | 3.32483560 |
| 58 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.31737045 |
| 59 | quaternary ammonium group transport (GO:0015697) | 3.28992380 |
| 60 | DNA double-strand break processing (GO:0000729) | 3.28667155 |
| 61 | cardiac muscle contraction (GO:0060048) | 3.28485377 |
| 62 | cardiac muscle cell development (GO:0055013) | 3.25886670 |
| 63 | regulation of skeletal muscle contraction (GO:0014819) | 3.25560728 |
| 64 | proteasome assembly (GO:0043248) | 3.23639792 |
| 65 | establishment of viral latency (GO:0019043) | 3.22741421 |
| 66 | L-serine metabolic process (GO:0006563) | 3.21921923 |
| 67 | acetyl-CoA metabolic process (GO:0006084) | 3.21214418 |
| 68 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.20870517 |
| 69 | positive regulation of fatty acid oxidation (GO:0046321) | 3.20644461 |
| 70 | negative regulation of ligase activity (GO:0051352) | 3.19398228 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.19398228 |
| 72 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.19219882 |
| 73 | actin-mediated cell contraction (GO:0070252) | 3.18619392 |
| 74 | glycolytic process (GO:0006096) | 3.18031488 |
| 75 | triglyceride catabolic process (GO:0019433) | 3.16471461 |
| 76 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.16259503 |
| 77 | IMP metabolic process (GO:0046040) | 3.15858788 |
| 78 | metaphase plate congression (GO:0051310) | 3.14162568 |
| 79 | NADPH regeneration (GO:0006740) | 3.12635747 |
| 80 | negative regulation of DNA recombination (GO:0045910) | 3.12325407 |
| 81 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.11377521 |
| 82 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.11377521 |
| 83 | negative regulation of cell size (GO:0045792) | 3.10929080 |
| 84 | mitochondrial fusion (GO:0008053) | 3.10558202 |
| 85 | IMP biosynthetic process (GO:0006188) | 3.09196799 |
| 86 | mitotic spindle checkpoint (GO:0071174) | 3.08628721 |
| 87 | mitotic metaphase plate congression (GO:0007080) | 3.08397861 |
| 88 | carnitine metabolic process (GO:0009437) | 3.07531619 |
| 89 | replication fork processing (GO:0031297) | 3.07189924 |
| 90 | cardiac cell development (GO:0055006) | 3.06803262 |
| 91 | spindle checkpoint (GO:0031577) | 3.06385257 |
| 92 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.05545305 |
| 93 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.05545305 |
| 94 | pyruvate metabolic process (GO:0006090) | 3.05345541 |
| 95 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.04792652 |
| 96 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.04407193 |
| 97 | protein localization to kinetochore (GO:0034501) | 3.04292328 |
| 98 | formation of translation preinitiation complex (GO:0001731) | 3.02187311 |
| 99 | ribosome assembly (GO:0042255) | 2.97955534 |
| 100 | DNA strand renaturation (GO:0000733) | 2.97671274 |
| 101 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.97057970 |
| 102 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.97057970 |
| 103 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.97057970 |
| 104 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.97057970 |
| 105 | negative regulation of sister chromatid segregation (GO:0033046) | 2.97057970 |
| 106 | purine nucleobase biosynthetic process (GO:0009113) | 2.94744659 |
| 107 | plasma membrane repair (GO:0001778) | 2.93923226 |
| 108 | regulation of mitochondrial translation (GO:0070129) | 2.92290425 |
| 109 | negative regulation of chromosome segregation (GO:0051985) | 2.91955264 |
| 110 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.91676020 |
| 111 | white fat cell differentiation (GO:0050872) | 2.90944810 |
| 112 | protein deneddylation (GO:0000338) | 2.90814480 |
| 113 | mitotic sister chromatid segregation (GO:0000070) | 2.89327149 |
| 114 | tRNA aminoacylation for protein translation (GO:0006418) | 2.89218544 |
| 115 | protein neddylation (GO:0045116) | 2.89049176 |
| 116 | creatine metabolic process (GO:0006600) | 2.88753610 |
| 117 | fatty acid homeostasis (GO:0055089) | 2.86652859 |
| 118 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.86113934 |
| 119 | peptidyl-lysine dimethylation (GO:0018027) | 2.85226902 |
| 120 | protein localization to chromosome, centromeric region (GO:0071459) | 2.85040707 |
| 121 | mitotic spindle assembly checkpoint (GO:0007094) | 2.83709362 |
| 122 | mitotic recombination (GO:0006312) | 2.83406649 |
| 123 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.82294625 |
| 124 | tRNA aminoacylation (GO:0043039) | 2.81379210 |
| 125 | amino acid activation (GO:0043038) | 2.81379210 |
| 126 | telomere maintenance via recombination (GO:0000722) | 2.80986348 |
| 127 | cardiolipin metabolic process (GO:0032048) | 2.80254996 |
| 128 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.80046558 |
| 129 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.80046558 |
| 130 | mitotic sister chromatid cohesion (GO:0007064) | 2.79462752 |
| 131 | sister chromatid segregation (GO:0000819) | 2.79159399 |
| 132 | actomyosin structure organization (GO:0031032) | 2.78831436 |
| 133 | spindle assembly checkpoint (GO:0071173) | 2.78684093 |
| 134 | brown fat cell differentiation (GO:0050873) | 2.78643322 |
| 135 | coenzyme A biosynthetic process (GO:0015937) | 2.78031309 |
| 136 | DNA replication checkpoint (GO:0000076) | 2.77795456 |
| 137 | acylglycerol catabolic process (GO:0046464) | 2.77442223 |
| 138 | neutral lipid catabolic process (GO:0046461) | 2.77442223 |
| 139 | cholesterol biosynthetic process (GO:0006695) | 2.76683417 |
| 140 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76597627 |
| 141 | resolution of meiotic recombination intermediates (GO:0000712) | 2.76086383 |
| 142 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.75995006 |
| 143 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.75995006 |
| 144 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.75995006 |
| 145 | DNA topological change (GO:0006265) | 2.75650034 |
| 146 | regulation of DNA endoreduplication (GO:0032875) | 2.75513992 |
| 147 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.74958161 |
| 148 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.74958161 |
| 149 | isotype switching (GO:0045190) | 2.74958161 |
| 150 | ribosomal small subunit assembly (GO:0000028) | 2.74488465 |
| 151 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.74242061 |
| 152 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.73351487 |
| 153 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.73351487 |
| 154 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.71755881 |
| 155 | thioester biosynthetic process (GO:0035384) | 2.71680093 |
| 156 | acyl-CoA biosynthetic process (GO:0071616) | 2.71680093 |
| 157 | positive regulation of ligase activity (GO:0051351) | 2.71453409 |
| 158 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.71061975 |
| 159 | ATP-dependent chromatin remodeling (GO:0043044) | 2.70954556 |
| 160 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.69254283 |
| 161 | monocarboxylic acid catabolic process (GO:0072329) | 2.63815120 |
| 162 | striated muscle contraction (GO:0006941) | 2.61850412 |
| 163 | binding of sperm to zona pellucida (GO:0007339) | 2.61842649 |
| 164 | heart trabecula formation (GO:0060347) | 2.61267503 |
| 165 | nuclear pore organization (GO:0006999) | 2.59131988 |
| 166 | intracellular lipid transport (GO:0032365) | 2.58901998 |
| 167 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.58604598 |
| 168 | gluconeogenesis (GO:0006094) | 2.57144278 |
| 169 | paraxial mesoderm development (GO:0048339) | 2.56017134 |
| 170 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.55642406 |
| 171 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.55434781 |
| 172 | sperm-egg recognition (GO:0035036) | 2.55110697 |
| 173 | mitotic nuclear envelope disassembly (GO:0007077) | 2.53276380 |
| 174 | cellular hyperosmotic response (GO:0071474) | 2.53091460 |
| 175 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.52976293 |
| 176 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.51773502 |
| 177 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.50166858 |
| 178 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.50166858 |
| 179 | alpha-linolenic acid metabolic process (GO:0036109) | 2.49054796 |
| 180 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.48663020 |
| 181 | positive regulation of lipid storage (GO:0010884) | 2.48139104 |
| 182 | heart process (GO:0003015) | 2.47853487 |
| 183 | heart contraction (GO:0060047) | 2.47853487 |
| 184 | regulation of fatty acid metabolic process (GO:0019217) | 2.47465301 |
| 185 | translesion synthesis (GO:0019985) | 2.46271028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.12532810 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.56900264 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.64804232 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.48219539 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.46359420 |
| 6 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.14981246 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.02000670 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.84290931 |
| 9 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.62606902 |
| 10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.52186964 |
| 11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27877826 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.25720913 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.20156364 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.12541865 |
| 15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.10916590 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.10754568 |
| 17 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.07803511 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.07624751 |
| 19 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.03779360 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.90512017 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.90206789 |
| 22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.88086310 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.87245014 |
| 24 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83790712 |
| 25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.79983915 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79510095 |
| 27 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.77086718 |
| 28 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.75482556 |
| 29 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.75391753 |
| 30 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.75280420 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74767020 |
| 32 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.70322846 |
| 33 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69718634 |
| 34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.68501943 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.64632577 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.64230853 |
| 37 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.60759854 |
| 38 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.59837836 |
| 39 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.53687798 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46752956 |
| 41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46714037 |
| 42 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.46042148 |
| 43 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.46041743 |
| 44 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.45944918 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.44994737 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.43350223 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.43350223 |
| 48 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.41499330 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41389561 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39935563 |
| 51 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.38898065 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38191646 |
| 53 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.37777982 |
| 54 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37451263 |
| 55 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.37225451 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37059983 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35822660 |
| 58 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.33198176 |
| 59 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31641311 |
| 60 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.31547832 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30943133 |
| 62 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30617948 |
| 63 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.30604018 |
| 64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29755203 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29271088 |
| 66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27380699 |
| 67 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.27190924 |
| 68 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.25347946 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24243428 |
| 70 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24145669 |
| 71 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.23432564 |
| 72 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.23318615 |
| 73 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.23158547 |
| 74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.23137413 |
| 75 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20250837 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18984748 |
| 77 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.18696463 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17078492 |
| 79 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16761351 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.15460223 |
| 81 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15319547 |
| 82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.15025715 |
| 83 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.13625473 |
| 84 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.13564275 |
| 85 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13328950 |
| 86 | P68_20966046_ChIP-Seq_HELA_Human | 1.12508057 |
| 87 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.11549806 |
| 88 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10955553 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10817612 |
| 90 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.10338175 |
| 91 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.09832092 |
| 92 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08045448 |
| 93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07802242 |
| 94 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07305065 |
| 95 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.06909963 |
| 96 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06548264 |
| 97 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06184935 |
| 98 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06047858 |
| 99 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05351518 |
| 100 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.05050119 |
| 101 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.04589000 |
| 102 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04433670 |
| 103 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.04375459 |
| 104 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.04314750 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03878373 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02702359 |
| 107 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.02188260 |
| 108 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02159232 |
| 109 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.02019719 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01851766 |
| 111 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.01848419 |
| 112 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00125156 |
| 113 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.97877744 |
| 114 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97828641 |
| 115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97722312 |
| 116 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96636361 |
| 117 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96564208 |
| 118 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.96453685 |
| 119 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95696228 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95583848 |
| 121 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95448576 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94595390 |
| 123 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94513471 |
| 124 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94231559 |
| 125 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94053544 |
| 126 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93216954 |
| 127 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92506125 |
| 128 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92347253 |
| 129 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.91795774 |
| 130 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90698269 |
| 131 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90513643 |
| 132 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.90273386 |
| 133 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.90205570 |
| 134 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89683762 |
| 135 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89565429 |
| 136 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88929952 |
| 137 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88448354 |
| 138 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.86491401 |
| 139 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86148832 |
| 140 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.85976618 |
| 141 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85621797 |
| 142 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82422676 |
| 143 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80419812 |
| 144 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.80390647 |
| 145 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.76642781 |
| 146 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.75469191 |
| 147 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.74815526 |
| 148 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.74048810 |
| 149 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.73855686 |
| 150 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.72655053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.25899647 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.24828252 |
| 3 | MP0005670_abnormal_white_adipose | 4.00661053 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.64507612 |
| 5 | MP0008058_abnormal_DNA_repair | 3.57739858 |
| 6 | MP0000751_myopathy | 3.24262384 |
| 7 | MP0004130_abnormal_muscle_cell | 3.22868131 |
| 8 | MP0005666_abnormal_adipose_tissue | 3.21717540 |
| 9 | MP0000749_muscle_degeneration | 2.86407873 |
| 10 | MP0009697_abnormal_copulation | 2.81543109 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.73856667 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.73690228 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.72798636 |
| 14 | MP0005330_cardiomyopathy | 2.66257334 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 2.52108466 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.47819480 |
| 17 | MP0008789_abnormal_olfactory_epithelium | 2.46946351 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.33850639 |
| 19 | MP0002269_muscular_atrophy | 2.27827771 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 2.23652679 |
| 21 | MP0004233_abnormal_muscle_weight | 2.22538629 |
| 22 | MP0000750_abnormal_muscle_regeneration | 2.21252901 |
| 23 | MP0005375_adipose_tissue_phenotype | 2.19549597 |
| 24 | MP0010630_abnormal_cardiac_muscle | 2.09925403 |
| 25 | MP0008775_abnormal_heart_ventricle | 2.07462410 |
| 26 | MP0003221_abnormal_cardiomyocyte_apopto | 2.05961236 |
| 27 | MP0003890_abnormal_embryonic-extraembry | 2.05707668 |
| 28 | MP0001293_anophthalmia | 2.01893913 |
| 29 | MP0003186_abnormal_redox_activity | 2.00307855 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.96207566 |
| 31 | MP0003718_maternal_effect | 1.93372620 |
| 32 | MP0005394_taste/olfaction_phenotype | 1.92885018 |
| 33 | MP0005499_abnormal_olfactory_system | 1.92885018 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.87102711 |
| 35 | MP0001529_abnormal_vocalization | 1.85413007 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.85317280 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.85317280 |
| 38 | MP0002233_abnormal_nose_morphology | 1.84374734 |
| 39 | MP0000747_muscle_weakness | 1.82170842 |
| 40 | MP0003941_abnormal_skin_development | 1.80499611 |
| 41 | MP0004145_abnormal_muscle_electrophysio | 1.80212454 |
| 42 | MP0000759_abnormal_skeletal_muscle | 1.79945033 |
| 43 | MP0005410_abnormal_fertilization | 1.76274504 |
| 44 | MP0005620_abnormal_muscle_contractility | 1.76038359 |
| 45 | MP0003122_maternal_imprinting | 1.72334001 |
| 46 | MP0006138_congestive_heart_failure | 1.70280591 |
| 47 | MP0002972_abnormal_cardiac_muscle | 1.70238358 |
| 48 | MP0003137_abnormal_impulse_conducting | 1.63772120 |
| 49 | MP0003121_genomic_imprinting | 1.59432984 |
| 50 | MP0002938_white_spotting | 1.52773469 |
| 51 | MP0003315_abnormal_perineum_morphology | 1.52633724 |
| 52 | MP0002971_abnormal_brown_adipose | 1.51335351 |
| 53 | MP0005369_muscle_phenotype | 1.47259456 |
| 54 | MP0003011_delayed_dark_adaptation | 1.46508263 |
| 55 | MP0001984_abnormal_olfaction | 1.42355394 |
| 56 | MP0003786_premature_aging | 1.41142052 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.37498079 |
| 58 | MP0003567_abnormal_fetal_cardiomyocyte | 1.36331638 |
| 59 | MP0003950_abnormal_plasma_membrane | 1.35215275 |
| 60 | MP0002102_abnormal_ear_morphology | 1.34639846 |
| 61 | MP0010094_abnormal_chromosome_stability | 1.31929187 |
| 62 | MP0005187_abnormal_penis_morphology | 1.30683567 |
| 63 | MP0001730_embryonic_growth_arrest | 1.30502043 |
| 64 | MP0008877_abnormal_DNA_methylation | 1.28821688 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 1.24360735 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 1.23981787 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.23496337 |
| 68 | MP0003077_abnormal_cell_cycle | 1.21904766 |
| 69 | MP0003111_abnormal_nucleus_morphology | 1.20973737 |
| 70 | MP0003984_embryonic_growth_retardation | 1.19796782 |
| 71 | MP0004957_abnormal_blastocyst_morpholog | 1.19004239 |
| 72 | MP0003385_abnormal_body_wall | 1.18742237 |
| 73 | MP0002088_abnormal_embryonic_growth/wei | 1.17057675 |
| 74 | MP0003828_pulmonary_edema | 1.15126759 |
| 75 | MP0002970_abnormal_white_adipose | 1.14898984 |
| 76 | MP0000647_abnormal_sebaceous_gland | 1.14300340 |
| 77 | MP0006035_abnormal_mitochondrial_morpho | 1.12050953 |
| 78 | MP0005266_abnormal_metabolism | 1.12022002 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.11234019 |
| 80 | MP0000266_abnormal_heart_morphology | 1.10943552 |
| 81 | * MP0001286_abnormal_eye_development | 1.08573923 |
| 82 | MP0004197_abnormal_fetal_growth/weight/ | 1.06226583 |
| 83 | MP0001672_abnormal_embryogenesis/_devel | 1.05763004 |
| 84 | MP0005380_embryogenesis_phenotype | 1.05763004 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 1.04664255 |
| 86 | MP0008961_abnormal_basal_metabolism | 1.03006166 |
| 87 | MP0009115_abnormal_fat_cell | 1.02591016 |
| 88 | MP0003937_abnormal_limbs/digits/tail_de | 1.01866382 |
| 89 | MP0002332_abnormal_exercise_endurance | 1.01391680 |
| 90 | MP0001697_abnormal_embryo_size | 1.00435319 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.98993807 |
| 92 | MP0005408_hypopigmentation | 0.98919537 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.98761730 |
| 94 | MP0003123_paternal_imprinting | 0.98465475 |
| 95 | MP0003755_abnormal_palate_morphology | 0.96250925 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.94807044 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.94426308 |
| 98 | MP0004484_altered_response_of | 0.93000108 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.92017965 |
| 100 | MP0000537_abnormal_urethra_morphology | 0.91310279 |
| 101 | MP0003787_abnormal_imprinting | 0.91182749 |
| 102 | MP0000733_abnormal_muscle_development | 0.91141655 |
| 103 | MP0000049_abnormal_middle_ear | 0.89888163 |
| 104 | MP0002127_abnormal_cardiovascular_syste | 0.89718922 |
| 105 | MP0002080_prenatal_lethality | 0.88628002 |
| 106 | MP0001764_abnormal_homeostasis | 0.88125847 |
| 107 | MP0003693_abnormal_embryo_hatching | 0.88100727 |
| 108 | * MP0002697_abnormal_eye_size | 0.87462632 |
| 109 | MP0009672_abnormal_birth_weight | 0.87410061 |
| 110 | MP0002084_abnormal_developmental_patter | 0.86768564 |
| 111 | MP0010030_abnormal_orbit_morphology | 0.83789534 |
| 112 | MP0000313_abnormal_cell_death | 0.83672898 |
| 113 | MP0001188_hyperpigmentation | 0.83600082 |
| 114 | MP0005334_abnormal_fat_pad | 0.82947311 |
| 115 | MP0010329_abnormal_lipoprotein_level | 0.82268424 |
| 116 | MP0000343_altered_response_to | 0.81884329 |
| 117 | MP0008057_abnormal_DNA_replication | 0.81121806 |
| 118 | MP0005085_abnormal_gallbladder_physiolo | 0.80746986 |
| 119 | MP0004147_increased_porphyrin_level | 0.80296578 |
| 120 | MP0001661_extended_life_span | 0.79209820 |
| 121 | MP0002085_abnormal_embryonic_tissue | 0.78822975 |
| 122 | MP0000358_abnormal_cell_content/ | 0.77949667 |
| 123 | MP0002396_abnormal_hematopoietic_system | 0.77788967 |
| 124 | MP0002751_abnormal_autonomic_nervous | 0.77484312 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.77374534 |
| 126 | * MP0001929_abnormal_gametogenesis | 0.75605356 |
| 127 | MP0002653_abnormal_ependyma_morphology | 0.75224763 |
| 128 | MP0000350_abnormal_cell_proliferation | 0.73244947 |
| 129 | MP0010307_abnormal_tumor_latency | 0.73137737 |
| 130 | MP0004133_heterotaxia | 0.72475237 |
| 131 | MP0002108_abnormal_muscle_morphology | 0.72437254 |
| 132 | MP0005253_abnormal_eye_physiology | 0.72374538 |
| 133 | * MP0002118_abnormal_lipid_homeostasis | 0.72153734 |
| 134 | * MP0002210_abnormal_sex_determination | 0.71899877 |
| 135 | MP0004085_abnormal_heartbeat | 0.71212121 |
| 136 | MP0002086_abnormal_extraembryonic_tissu | 0.71134409 |
| 137 | MP0003119_abnormal_digestive_system | 0.68951237 |
| 138 | MP0005332_abnormal_amino_acid | 0.68604710 |
| 139 | MP0001299_abnormal_eye_distance/ | 0.68349976 |
| 140 | MP0009703_decreased_birth_body | 0.67882509 |
| 141 | * MP0000653_abnormal_sex_gland | 0.67842596 |
| 142 | MP0005275_abnormal_skin_tensile | 0.66571154 |
| 143 | MP0003115_abnormal_respiratory_system | 0.66284100 |
| 144 | MP0005365_abnormal_bile_salt | 0.65683188 |
| 145 | MP0002078_abnormal_glucose_homeostasis | 0.65566413 |
| 146 | MP0000609_abnormal_liver_physiology | 0.64983983 |
| 147 | MP0003283_abnormal_digestive_organ | 0.64360419 |
| 148 | MP0008007_abnormal_cellular_replicative | 0.64194168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myoglobinuria (HP:0002913) | 6.39453056 |
| 2 | Rhabdomyolysis (HP:0003201) | 5.66504441 |
| 3 | Exercise-induced myalgia (HP:0003738) | 5.41981204 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 5.41432092 |
| 5 | Sudden death (HP:0001699) | 4.48307858 |
| 6 | Difficulty running (HP:0009046) | 4.20947580 |
| 7 | Ventricular tachycardia (HP:0004756) | 4.13143447 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 3.88863938 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 3.85611495 |
| 10 | Lipoatrophy (HP:0100578) | 3.77855283 |
| 11 | Muscle fiber splitting (HP:0003555) | 3.74274852 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.74086935 |
| 13 | Increased connective tissue (HP:0009025) | 3.60883766 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.58584282 |
| 15 | Colon cancer (HP:0003003) | 3.52042709 |
| 16 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.45247516 |
| 17 | Dicarboxylic aciduria (HP:0003215) | 3.33696564 |
| 18 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.33696564 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.32279375 |
| 20 | Hyperglycinuria (HP:0003108) | 3.23340079 |
| 21 | Atrial fibrillation (HP:0005110) | 3.18466952 |
| 22 | Dilated cardiomyopathy (HP:0001644) | 3.18197366 |
| 23 | Ketoacidosis (HP:0001993) | 3.17853615 |
| 24 | Palpitations (HP:0001962) | 3.13958123 |
| 25 | Type 1 muscle fiber predominance (HP:0003803) | 3.09754943 |
| 26 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.09293877 |
| 27 | Subaortic stenosis (HP:0001682) | 3.09293877 |
| 28 | Hepatic necrosis (HP:0002605) | 3.02976386 |
| 29 | Rimmed vacuoles (HP:0003805) | 3.02925069 |
| 30 | Muscle fiber inclusion bodies (HP:0100299) | 3.00408983 |
| 31 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.96552926 |
| 32 | Abnormality of the calf musculature (HP:0001430) | 2.96093529 |
| 33 | Ketosis (HP:0001946) | 2.94944028 |
| 34 | Increased muscle lipid content (HP:0009058) | 2.94067792 |
| 35 | Primary atrial arrhythmia (HP:0001692) | 2.93285739 |
| 36 | Supraventricular tachycardia (HP:0004755) | 2.92738036 |
| 37 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.90632736 |
| 38 | Supraventricular arrhythmia (HP:0005115) | 2.89751145 |
| 39 | Chromsome breakage (HP:0040012) | 2.86105360 |
| 40 | Asymmetric septal hypertrophy (HP:0001670) | 2.85911098 |
| 41 | Muscle stiffness (HP:0003552) | 2.84641478 |
| 42 | Multiple enchondromatosis (HP:0005701) | 2.83614012 |
| 43 | Right ventricular cardiomyopathy (HP:0011663) | 2.79455595 |
| 44 | Reticulocytopenia (HP:0001896) | 2.78592815 |
| 45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77798342 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 2.77798342 |
| 47 | Hyperglycinemia (HP:0002154) | 2.77415435 |
| 48 | Ependymoma (HP:0002888) | 2.72298553 |
| 49 | Hyperammonemia (HP:0001987) | 2.69764408 |
| 50 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.68181206 |
| 51 | Ragged-red muscle fibers (HP:0003200) | 2.66742571 |
| 52 | Abnormality of the labia minora (HP:0012880) | 2.62733346 |
| 53 | Increased serum pyruvate (HP:0003542) | 2.61417367 |
| 54 | Abnormality of glycolysis (HP:0004366) | 2.61417367 |
| 55 | Progressive macrocephaly (HP:0004481) | 2.60628699 |
| 56 | EMG: myopathic abnormalities (HP:0003458) | 2.59426086 |
| 57 | Cortical dysplasia (HP:0002539) | 2.58094575 |
| 58 | Difficulty climbing stairs (HP:0003551) | 2.54417963 |
| 59 | Microvesicular hepatic steatosis (HP:0001414) | 2.50283954 |
| 60 | Bundle branch block (HP:0011710) | 2.48697365 |
| 61 | Nemaline bodies (HP:0003798) | 2.48694024 |
| 62 | Generalized aminoaciduria (HP:0002909) | 2.45844118 |
| 63 | Hyperalaninemia (HP:0003348) | 2.45783292 |
| 64 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.45783292 |
| 65 | Abnormality of alanine metabolism (HP:0010916) | 2.45783292 |
| 66 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.43344678 |
| 67 | Increased CSF lactate (HP:0002490) | 2.42847159 |
| 68 | Hypobetalipoproteinemia (HP:0003563) | 2.41980092 |
| 69 | Calcaneovalgus deformity (HP:0001848) | 2.41967064 |
| 70 | Nausea (HP:0002018) | 2.41719522 |
| 71 | Long clavicles (HP:0000890) | 2.41027323 |
| 72 | Meckel diverticulum (HP:0002245) | 2.40332000 |
| 73 | Mitochondrial inheritance (HP:0001427) | 2.40021938 |
| 74 | Abnormality of methionine metabolism (HP:0010901) | 2.37920745 |
| 75 | Abnormality of serum amino acid levels (HP:0003112) | 2.36798286 |
| 76 | Abnormal lung lobation (HP:0002101) | 2.35518001 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.35445470 |
| 78 | Medulloblastoma (HP:0002885) | 2.31979278 |
| 79 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.30526472 |
| 80 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.30526472 |
| 81 | Abnormality of chromosome stability (HP:0003220) | 2.26787956 |
| 82 | Atrioventricular block (HP:0001678) | 2.26756722 |
| 83 | Deformed tarsal bones (HP:0008119) | 2.25313466 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24001404 |
| 85 | Ventricular arrhythmia (HP:0004308) | 2.23824068 |
| 86 | Abnormality of the ileum (HP:0001549) | 2.23659686 |
| 87 | Myotonia (HP:0002486) | 2.22980066 |
| 88 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.22826253 |
| 89 | Hepatoblastoma (HP:0002884) | 2.21598187 |
| 90 | Hepatocellular necrosis (HP:0001404) | 2.21454649 |
| 91 | Adenoma sebaceum (HP:0009720) | 2.19642626 |
| 92 | Angiofibromas (HP:0010615) | 2.19642626 |
| 93 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.16060768 |
| 94 | Type 2 muscle fiber atrophy (HP:0003554) | 2.14149172 |
| 95 | Rhabdomyosarcoma (HP:0002859) | 2.11082570 |
| 96 | Increased hepatocellular lipid droplets (HP:0006565) | 2.09868787 |
| 97 | Neck muscle weakness (HP:0000467) | 2.09682760 |
| 98 | Hypoplastic pelvis (HP:0008839) | 2.09443032 |
| 99 | Heart block (HP:0012722) | 2.09267204 |
| 100 | Limb-girdle muscle atrophy (HP:0003797) | 2.06091069 |
| 101 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.06001509 |
| 102 | Proximal tubulopathy (HP:0000114) | 2.05238396 |
| 103 | Lactic acidosis (HP:0003128) | 2.03910187 |
| 104 | Hypertriglyceridemia (HP:0002155) | 2.03853519 |
| 105 | EMG: neuropathic changes (HP:0003445) | 2.03607477 |
| 106 | Hamartoma of the eye (HP:0010568) | 2.02684617 |
| 107 | Neoplasm of the adrenal gland (HP:0100631) | 2.02633087 |
| 108 | Abnormality of the preputium (HP:0100587) | 2.02333014 |
| 109 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01634685 |
| 110 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99457451 |
| 111 | Ulnar deviation of the wrist (HP:0003049) | 1.99416994 |
| 112 | Postnatal microcephaly (HP:0005484) | 1.98592801 |
| 113 | Distal arthrogryposis (HP:0005684) | 1.97914652 |
| 114 | Increased serum lactate (HP:0002151) | 1.97911921 |
| 115 | Cerebral edema (HP:0002181) | 1.95349433 |
| 116 | Papillary thyroid carcinoma (HP:0002895) | 1.93844973 |
| 117 | Progressive muscle weakness (HP:0003323) | 1.93804961 |
| 118 | Large hands (HP:0001176) | 1.93264463 |
| 119 | Proximal amyotrophy (HP:0007126) | 1.92932725 |
| 120 | Oligomenorrhea (HP:0000876) | 1.92716337 |
| 121 | Conjunctival hamartoma (HP:0100780) | 1.92170969 |
| 122 | Syncope (HP:0001279) | 1.91186002 |
| 123 | Type I transferrin isoform profile (HP:0003642) | 1.89532904 |
| 124 | Prenatal maternal abnormality (HP:0002686) | 1.89027232 |
| 125 | Facial diplegia (HP:0001349) | 1.88573553 |
| 126 | Generalized muscle weakness (HP:0003324) | 1.87435559 |
| 127 | Abnormality of the astrocytes (HP:0100707) | 1.87178562 |
| 128 | Astrocytoma (HP:0009592) | 1.87178562 |
| 129 | Myopathic facies (HP:0002058) | 1.87075511 |
| 130 | Toxemia of pregnancy (HP:0100603) | 1.86311051 |
| 131 | Supernumerary spleens (HP:0009799) | 1.86218953 |
| 132 | Exercise intolerance (HP:0003546) | 1.85503640 |
| 133 | Neoplasm of the rectum (HP:0100743) | 1.85425966 |
| 134 | Shoulder girdle muscle weakness (HP:0003547) | 1.85290370 |
| 135 | Insulin resistance (HP:0000855) | 1.85001067 |
| 136 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.84684519 |
| 137 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.84684519 |
| 138 | Prolonged QT interval (HP:0001657) | 1.84263716 |
| 139 | Abnormal atrioventricular conduction (HP:0005150) | 1.84201007 |
| 140 | Methylmalonic aciduria (HP:0012120) | 1.83081333 |
| 141 | Neoplasm of head and neck (HP:0012288) | 1.82930978 |
| 142 | Esophageal neoplasm (HP:0100751) | 1.82930978 |
| 143 | Acute encephalopathy (HP:0006846) | 1.82856616 |
| 144 | Acanthosis nigricans (HP:0000956) | 1.82585399 |
| 145 | Muscle fiber atrophy (HP:0100295) | 1.81287645 |
| 146 | Progressive external ophthalmoplegia (HP:0000590) | 1.80177010 |
| 147 | Secondary amenorrhea (HP:0000869) | 1.79952560 |
| 148 | Amniotic constriction ring (HP:0009775) | 1.78331753 |
| 149 | Abnormality of placental membranes (HP:0011409) | 1.78331753 |
| 150 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.78153081 |
| 151 | Leukodystrophy (HP:0002415) | 1.75951392 |
| 152 | Renal cortical cysts (HP:0000803) | 1.74961393 |
| 153 | Methylmalonic acidemia (HP:0002912) | 1.74533004 |
| 154 | Lethargy (HP:0001254) | 1.72704257 |
| 155 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.72371536 |
| 156 | Duodenal stenosis (HP:0100867) | 1.72068599 |
| 157 | Small intestinal stenosis (HP:0012848) | 1.72068599 |
| 158 | Neoplasm of the colon (HP:0100273) | 1.71749516 |
| 159 | Acanthocytosis (HP:0001927) | 1.70725680 |
| 160 | Embryonal renal neoplasm (HP:0011794) | 1.69929838 |
| 161 | Respiratory failure (HP:0002878) | 1.68912474 |
| 162 | Malignant hyperthermia (HP:0002047) | 1.68255140 |
| 163 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.66774202 |
| 164 | Hypolipoproteinemia (HP:0010981) | 1.66038317 |
| 165 | Myelodysplasia (HP:0002863) | 1.64329843 |
| 166 | Premature ovarian failure (HP:0008209) | 1.63043819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK4 | 4.68827043 |
| 2 | PDK3 | 4.68827043 |
| 3 | BCKDK | 4.03308189 |
| 4 | TRIB3 | 3.74480731 |
| 5 | TTN | 3.59096159 |
| 6 | PKN2 | 3.38668810 |
| 7 | TRIM28 | 2.94894564 |
| 8 | PBK | 2.84900492 |
| 9 | OBSCN | 2.80734651 |
| 10 | NEK1 | 2.60950348 |
| 11 | BCR | 2.52281402 |
| 12 | ZAK | 2.45629860 |
| 13 | PDK2 | 2.42805125 |
| 14 | MKNK1 | 2.37629348 |
| 15 | EEF2K | 2.27288057 |
| 16 | MAP3K10 | 2.16097591 |
| 17 | EIF2AK3 | 2.09708826 |
| 18 | PLK3 | 1.97545226 |
| 19 | TESK1 | 1.88947163 |
| 20 | ICK | 1.86465378 |
| 21 | TSSK6 | 1.79799528 |
| 22 | PHKG1 | 1.79568858 |
| 23 | PHKG2 | 1.79568858 |
| 24 | LMTK2 | 1.74759139 |
| 25 | PLK4 | 1.71872704 |
| 26 | MKNK2 | 1.70758303 |
| 27 | NME1 | 1.67644028 |
| 28 | MST4 | 1.65595668 |
| 29 | TNIK | 1.64767516 |
| 30 | VRK2 | 1.60110316 |
| 31 | SIK1 | 1.58890294 |
| 32 | FLT3 | 1.55027201 |
| 33 | NEK2 | 1.49877595 |
| 34 | CDC7 | 1.49479210 |
| 35 | WNK3 | 1.45591453 |
| 36 | CAMK1D | 1.44948989 |
| 37 | STK16 | 1.37094664 |
| 38 | VRK1 | 1.36603638 |
| 39 | MAP3K4 | 1.30224740 |
| 40 | BMPR1B | 1.28660189 |
| 41 | ERBB3 | 1.28375619 |
| 42 | MYLK | 1.23896567 |
| 43 | PRKD3 | 1.22666534 |
| 44 | BUB1 | 1.22345916 |
| 45 | WEE1 | 1.19554372 |
| 46 | EIF2AK1 | 1.18966908 |
| 47 | MAP4K2 | 1.18374220 |
| 48 | MAP2K7 | 1.16294490 |
| 49 | MAP2K3 | 1.15059306 |
| 50 | CSNK1G3 | 1.12043212 |
| 51 | CCNB1 | 1.11762652 |
| 52 | TTK | 1.08668720 |
| 53 | CSNK1G1 | 1.07356209 |
| 54 | CDK4 | 1.06972166 |
| 55 | ERN1 | 1.06289873 |
| 56 | PASK | 1.06173665 |
| 57 | ILK | 1.04492269 |
| 58 | DMPK | 1.03569546 |
| 59 | CDK12 | 1.01218337 |
| 60 | PAK4 | 0.99355185 |
| 61 | LRRK2 | 0.96105488 |
| 62 | MTOR | 0.95161571 |
| 63 | TGFBR1 | 0.94681241 |
| 64 | STK24 | 0.93919066 |
| 65 | NUAK1 | 0.93169934 |
| 66 | MAPKAPK3 | 0.93096436 |
| 67 | PINK1 | 0.92669933 |
| 68 | TESK2 | 0.92051268 |
| 69 | PNCK | 0.91534072 |
| 70 | CSNK1G2 | 0.90997339 |
| 71 | DYRK3 | 0.88889021 |
| 72 | CAMK1G | 0.88398460 |
| 73 | BRAF | 0.85123616 |
| 74 | FGFR1 | 0.84648909 |
| 75 | CHEK2 | 0.83971740 |
| 76 | STK10 | 0.81786018 |
| 77 | TAF1 | 0.81458952 |
| 78 | CSNK1A1L | 0.80038843 |
| 79 | SCYL2 | 0.78918570 |
| 80 | KDR | 0.77607809 |
| 81 | EIF2AK2 | 0.77171381 |
| 82 | STK4 | 0.76972894 |
| 83 | MAP3K8 | 0.74874012 |
| 84 | PLK2 | 0.74737532 |
| 85 | ATR | 0.71955171 |
| 86 | PDGFRA | 0.71650055 |
| 87 | MAPK11 | 0.69225041 |
| 88 | RIPK1 | 0.68308054 |
| 89 | DYRK2 | 0.67559767 |
| 90 | TIE1 | 0.67099578 |
| 91 | CASK | 0.67051796 |
| 92 | RPS6KB2 | 0.66073482 |
| 93 | BRSK1 | 0.65538488 |
| 94 | PRKAA1 | 0.65052396 |
| 95 | CDK19 | 0.64985082 |
| 96 | STK3 | 0.64267613 |
| 97 | PTK6 | 0.63191505 |
| 98 | CDK6 | 0.62646371 |
| 99 | MAP3K11 | 0.62603394 |
| 100 | MAP3K12 | 0.61924777 |
| 101 | AKT2 | 0.61767187 |
| 102 | MINK1 | 0.60813380 |
| 103 | MAP3K7 | 0.60489792 |
| 104 | CSNK2A2 | 0.60365448 |
| 105 | CDK18 | 0.55686674 |
| 106 | WNK4 | 0.55064112 |
| 107 | CSNK2A1 | 0.54296585 |
| 108 | CDK14 | 0.53161974 |
| 109 | AURKB | 0.53083297 |
| 110 | STK38L | 0.52954789 |
| 111 | PRKAA2 | 0.52941106 |
| 112 | BRD4 | 0.51353874 |
| 113 | MAP4K1 | 0.51277085 |
| 114 | CSNK1E | 0.50918678 |
| 115 | ALK | 0.50716807 |
| 116 | PLK1 | 0.50173551 |
| 117 | CDK15 | 0.49350936 |
| 118 | MUSK | 0.49202256 |
| 119 | CDK7 | 0.48222703 |
| 120 | CDK11A | 0.46919058 |
| 121 | EPHB2 | 0.46354756 |
| 122 | CHEK1 | 0.46074961 |
| 123 | MAP2K4 | 0.45965984 |
| 124 | PAK2 | 0.45693652 |
| 125 | PIK3CA | 0.43621395 |
| 126 | LATS1 | 0.43483168 |
| 127 | PRKDC | 0.42507122 |
| 128 | CDK1 | 0.40205115 |
| 129 | PRKD1 | 0.39258621 |
| 130 | MET | 0.38031061 |
| 131 | DYRK1B | 0.36928249 |
| 132 | CDK8 | 0.35857807 |
| 133 | PDK1 | 0.35516050 |
| 134 | RPS6KA1 | 0.34565537 |
| 135 | LIMK1 | 0.34317195 |
| 136 | BRSK2 | 0.33966714 |
| 137 | NEK9 | 0.33837672 |
| 138 | LATS2 | 0.33069751 |
| 139 | ACVR1B | 0.31986523 |
| 140 | MAP2K6 | 0.31530620 |
| 141 | INSRR | 0.30729657 |
| 142 | ARAF | 0.30617739 |
| 143 | STK38 | 0.29974386 |
| 144 | MAP3K5 | 0.28981740 |
| 145 | TGFBR2 | 0.28171640 |
| 146 | AURKA | 0.27973606 |
| 147 | SRPK1 | 0.27968496 |
| 148 | CDK9 | 0.26975020 |
| 149 | ZAP70 | 0.26968579 |
| 150 | PTK2B | 0.26913098 |
| 151 | PIK3CG | 0.26542400 |
| 152 | ATM | 0.26130517 |
| 153 | CDK2 | 0.25323598 |
| 154 | FGFR4 | 0.23852585 |
| 155 | CDC42BPA | 0.23822892 |
| 156 | RPS6KA4 | 0.22895915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.67478138 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.16140829 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.09317854 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.16329090 |
| 5 | Carbon metabolism_Homo sapiens_hsa01200 | 3.06894375 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.79034579 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.76036816 |
| 8 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.62926208 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.42098219 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34115500 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.29121359 |
| 12 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.16356326 |
| 13 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.15871091 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 2.14692305 |
| 15 | Protein export_Homo sapiens_hsa03060 | 2.11482649 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.05616849 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.90359744 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.75011655 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.61889294 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.53734937 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51319072 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.45755509 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.35455608 |
| 24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.31155959 |
| 25 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.30462534 |
| 26 | Lysine degradation_Homo sapiens_hsa00310 | 1.28861363 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.23366427 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.21659516 |
| 29 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.21250927 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.17822080 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.17409069 |
| 32 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.15056916 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14938913 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08079031 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06176000 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.05104953 |
| 37 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05027964 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02843093 |
| 39 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01707670 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98998339 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98388753 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98263227 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97757159 |
| 44 | Insulin resistance_Homo sapiens_hsa04931 | 0.95340049 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93991495 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90765685 |
| 47 | Cell cycle_Homo sapiens_hsa04110 | 0.89215580 |
| 48 | Spliceosome_Homo sapiens_hsa03040 | 0.88952422 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88199136 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88031183 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87635540 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87053801 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83175275 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81570733 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79729317 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79406193 |
| 57 | * Peroxisome_Homo sapiens_hsa04146 | 0.78966284 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78191171 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76448775 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.76247941 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75583899 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72879847 |
| 63 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.71778116 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70144168 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70022441 |
| 66 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69797989 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68572219 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.68444441 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.68129152 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67562417 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66860364 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62650493 |
| 73 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.61044164 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60702229 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59656440 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58161199 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58125687 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57842326 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56828605 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55602533 |
| 81 | RNA degradation_Homo sapiens_hsa03018 | 0.54467816 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53804876 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52363423 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51213069 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51144209 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50617319 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49962999 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48489590 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48222830 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48196984 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47879147 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47271390 |
| 93 | Ribosome_Homo sapiens_hsa03010 | 0.46409208 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45461492 |
| 95 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44188979 |
| 96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43840192 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42165920 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41826261 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41558838 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.41518960 |
| 101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41172656 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39818073 |
| 103 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37871696 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36858595 |
| 105 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.36477288 |
| 106 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.35876629 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34984311 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32991397 |
| 109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32576085 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32022300 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30108080 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27964897 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27396617 |
| 114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26643215 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.25942418 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25635843 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25492470 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.24303458 |
| 119 | Adherens junction_Homo sapiens_hsa04520 | 0.24198775 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23627147 |
| 121 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.23403846 |
| 122 | Proteasome_Homo sapiens_hsa03050 | 0.23365742 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23259242 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.17121204 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.14718921 |
| 126 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.13465031 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.11542204 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.11432604 |

